← Back to headlines
UBS Cuts Boston Scientific Target Price While Maintaining 'Buy' Rating
UBS has reportedly cut its target price for Boston Scientific but continues to recommend the stock as a 'buy'.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
